Fixed-dose combination antituberculosis therapy as a risk factor for tuberculosis recurrence: an evidence-based case report

Fixed-dose combination antituberculosis therapy as a risk factor for tuberculosis recurrence: an evidence-based case report

Background: a patient with a history of tuberculosis (TB) has a risk up to 27% to develop recurrence within 2 years after being cured. Indonesia itself has more than 7,500 recurrent cases annually, regardless of reinfection or relapse. This is an important problem, as recurrent TB is associated with...

Descrición completa

Detalles Bibliográficos
Main Authors: Arvin Pramudita, Cleopas M Rumende, Ardi Findyartini
Formato: Artigo
Idioma:English
Publicado: Interna Publishing 2017-04-01
Series:Acta Medica Indonesiana
Subjects:
tuberculosis
fixed-dose combination
recurrent
Acceso en liña:http://www.actamedindones.org/index.php/ijim/article/view/327

Títulos similares

Títulos similares